Chen Liang, Campisi Alessio, Wang Zhexin, Dell'Amore Andrea, Ciarrocchi Angelo Paolo, Zhao Heng, Stella Franco, Yao Feng
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Thoracic Surgery Unit, Department of Thoracic Diseases, G.B. Morgagni-L. Pierantoni Hospital, Forlì, Italy.
JTCVS Tech. 2021 May 19;8:196-201. doi: 10.1016/j.xjtc.2021.05.013. eCollection 2021 Aug.
A rare and complex procedure, total lung sparing left secondary carinal resection and reconstruction is only performed in a few specialized centers in a restricted group of patients. We reviewed our experience to evaluate its safety.
Patients who underwent left secondary carinal resection and reconstruction with complete lung parenchymal preservation for low-grade bronchial malignancies at the Shanghai Chest Hospital and the Padua University Hospital were retrospectively reviewed. Clinicopathologic factors and perioperative outcomes were analyzed.
Thirty patients underwent the procedure between July 2012 and July 2019 (mean age, 42.9 years). No operative mortality occurred and postoperative complications developed in 4 patients (13.3%), including pneumonia (n = 3 [10.0%]), subcutaneous emphysema (n = 2 [6.7%]), and prolonged air leak (n = 2 [6.7%]). Pathologies included adenoid cystic carcinoma (n = 11), mucoepidermoid carcinoma (n = 6), carcinoid tumors (n = 9 [8 typical and 1 atypical subtypes]), inflammatory myofibroblastic tumor (n = 3), and myoepithelioma (n = 1). The margins were positive in 8 patients (26.7%), whereas 2 patients (6.7%) had positive lymph nodes. Adjuvant therapies were performed postoperatively, including chemoradiotherapy for positive lymph nodes and radiotherapy for positive margins.
Total lung sparing left secondary carinal resection and reconstruction can be performed safely in well-selected and oncologically appropriate patients with low-grade bronchial malignancies.
全肺保留的左肺叶支气管隆突切除重建术是一种罕见且复杂的手术,仅在少数专业中心针对特定患者群体开展。我们回顾了自身经验以评估其安全性。
对在上海胸科医院和帕多瓦大学医院接受全肺保留的左肺叶支气管隆突切除重建术以治疗低度恶性支气管肿瘤的患者进行回顾性研究。分析临床病理因素和围手术期结果。
2012年7月至2019年7月期间,30例患者接受了该手术(平均年龄42.9岁)。无手术死亡病例,4例患者(13.3%)出现术后并发症,包括肺炎(3例[10.0%])、皮下气肿(2例[6.7%])和持续漏气(2例[6.7%])。病理类型包括腺样囊性癌(11例)、黏液表皮样癌(6例)、类癌肿瘤(9例[8例典型和1例非典型亚型])、炎性肌纤维母细胞瘤(3例)和肌上皮瘤(1例)。8例患者(26.7%)切缘阳性,2例患者(6.7%)有阳性淋巴结。术后进行了辅助治疗,包括对阳性淋巴结进行放化疗以及对阳性切缘进行放疗。
对于精心挑选且肿瘤学上合适的低度恶性支气管肿瘤患者,全肺保留的左肺叶支气管隆突切除重建术可安全实施。